- 83.9k views
Pediatric Muscular Dystrophy
Pediatric muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration in children. The most common type, Duchenne muscular dystrophy (DMD), typically manifests in early childhood, often between the ages of 2 and 5. Children with this condition experience difficulty with motor functions, such as walking, climbing stairs, and maintaining balance. As the disease progresses, it can affect the heart and respiratory muscles, leading to more severe health complications. Early diagnosis and intervention, including physical therapy, medications, and sometimes surgical treatments, are crucial in managing symptoms and improving quality of life for affected children. Research into gene therapy and other advanced treatments continues to offer hope for more effective therapies in the future.
About the Speaker
Dr. Rama Krishna Cheruvu
Senior Consultant Pediatrician, Mayflower Hospital, Hyderabad
Dr. Rama Krishna Cheruvuis currently working as Senior Consultant Pediatrician, Mayflower Hospital, Hyderabad. He is a highly experienced pediatrician with over 20 years of clinical experience. Graduating as the best outgoing student and recipient of the Dr. Lavanya Mukherjee Prize from Andhra Medical College, Visakhapatnam, in 2001, Dr. [Name] also holds a postgraduate degree in Clinical Research and Regulatory Affairs from Sikkim Manipal University. As a life member of the Indian Academy of Pediatrics (IAP), Dr. [Name] actively participates in community health programs and serves as a speaker and delegate in local IAP events. Currently, Dr. [Name] is a Senior Consultant Pediatrician at Mayflower Hospital and Trinity Hospital in Hyderabad, with special interests in infectious diseases, immunization, child growth, nutrition, and adolescent counseling.
Upcoming Case Discussions
Preparing your Practice for Adoption of AI
Preparing Your Practice for Adoption of AI" involves building a foundation of digital literacy, data readiness, and ethical awareness among clinicians and staff. Successful integration starts with identifying key workflows where AI can enhance efficiency, accuracy, or patient outcomes. It’s essential to choose tools that align with your practice’s goals while ensuring transparency, security, and compliance. Training, change management, and continuous evaluation are critical to fostering trust and long-term adoption. Ultimately, AI should support—not replace—the human touch in medicine.
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Approach to Child with Status Epilepticus
Status epilepticus (SE) in children is a neurological emergency defined as a seizure lasting >5 minutes or recurrent seizures without recovery between episodes. Initial assessment includes airway, breathing, and circulation stabilization, followed by rapid glucose and electrolyte correction. First-line treatment involves benzodiazepines (e.g., lorazepam or midazolam). If seizures persist, second-line agents like phenytoin, levetiracetam, or valproate are administered. Refractory SE requires ICU admission and continuous infusion of anesthetics like midazolam or thiopental. Etiology must be identified (e.g., infection, metabolic, structural, or toxic causes). Prompt intervention reduces risk of neurological damage and improves outcomes. Continuous EEG monitoring may be necessary.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Rama Krishna Cheruvu's Talks on Assimilate
- 26th-June-2024, TIME : 5:00PM TO 6:00 PM
- 0
Pediatric muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration in children. The most common type, Duchenne muscular dystrophy (DMD), typically manifests in early childhood, often between the ages of 2 and 5. Children with this condition experience difficulty with motor functions, such as walking, climbing stairs, and maintaining balance. As the disease progresses, it can affect the heart and respiratory muscles, leading to more severe health complications. Early diagnosis and intervention, including physical therapy, medications, and sometimes surgical treatments, are crucial in managing symptoms and improving quality of life for affected children. Research into gene therapy and other advanced treatments continues to offer hope for more effective therapies in the future.
- 26th-June-2024, TIME : 5:00PM TO 6:00 PM
- 0
Pediatric muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration in children. The most common type, Duchenne muscular dystrophy (DMD), typically manifests in early childhood, often between the ages of 2 and 5. Children with this condition experience difficulty with motor functions, such as walking, climbing stairs, and maintaining balance. As the disease progresses, it can affect the heart and respiratory muscles, leading to more severe health complications. Early diagnosis and intervention, including physical therapy, medications, and sometimes surgical treatments, are crucial in managing symptoms and improving quality of life for affected children. Research into gene therapy and other advanced treatments continues to offer hope for more effective therapies in the future.